Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus: A Prospective, Multicenter, Randomized, Blank-controlled Blinded End-point Study.
Latest Information Update: 14 Feb 2023
At a glance
- Drugs Liraglutide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms LAMP
- 02 Feb 2023 Planned End Date changed from 1 Dec 2023 to 1 Jun 2024.
- 02 Feb 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Dec 2023.
- 17 Mar 2022 Planned End Date changed from 1 May 2023 to 1 Dec 2023.